drugset / Trial / NCT00018161

Treatment to Quit Smoking

NCT00018161

RandomizedParallel-groupDouble-blindTreatment

Summary

This protocol evaluates the efficacy of combining pharmacologic treatments for smoking cessation, entailing the use of the nicotine skin patch with the nicotinic antagonist mecamylamine, with a specific behavioral therapy designed to inhibit the smoking urge.

Timeline

Start
1997-01
Primary completion
Completion
2001-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Mecamylamine Small molecule
Subject Nicotine Unknown Other

Indications

No indication recorded.